Progyny Inc
NASDAQ:PGNY

Watchlist Manager
Progyny Inc Logo
Progyny Inc
NASDAQ:PGNY
Watchlist
Price: 18.17 USD 2.83% Market Closed
Market Cap: $1.5B

P/OCF

7.1
Current
42%
Cheaper
vs 3-y average of 12.2

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
7.1
=
Market Cap
$1.5B
/
Operating Cash Flow
$210.2m

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
7.1
=
Market Cap
$1.5B
/
Operating Cash Flow
$210.2m

Valuation Scenarios

Progyny Inc is trading below its 3-year average

If P/OCF returns to its 3-Year Average (12.2), the stock would be worth $31.41 (73% upside from current price).

Statistics
Positive Scenarios
4/4
Maximum Downside
No Downside Scenarios
Maximum Upside
+197%
Average Upside
121%
Scenario P/OCF Value Implied Price Upside/Downside
Current Multiple 7.1 $18.17
0%
3-Year Average 12.2 $31.41
+73%
5-Year Average 21 $53.94
+197%
Industry Average 16.1 $41.27
+127%
Country Average 13.3 $34.26
+89%

Forward P/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward P/OCF

Peer Comparison

All Multiples
P/OCF
P/E
All Countries
Close
P/E Multiple
Earnings Growth PEG
US
Progyny Inc
NASDAQ:PGNY
Average P/E: 23.2
25.4
35%
0.7
US
UnitedHealth Group Inc
NYSE:UNH
26.7
22%
1.2
US
A
Anthem Inc
LSE:0HG8
17
10%
1.7
US
Elevance Health Inc
NYSE:ELV
14.3
10%
1.4
US
Humana Inc
NYSE:HUM
21.8
38%
0.6
US
Centene Corp
NYSE:CNC
Negative Multiple: -3.1 N/A N/A
US
Molina Healthcare Inc
NYSE:MOH
48.7
14%
3.5
US
Healthequity Inc
NASDAQ:HQY
32.6
32%
1
US
M
Magellan Health Inc
F:MAH1
8.5
N/A N/A
BR
Odontoprev SA
BOVESPA:ODPV3
14
4%
3.5
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
Negative Multiple: -45.7 N/A N/A

Market Distribution

Lower than 79% of companies in the United States of America
Percentile
21st
Based on 9 488 companies
21st percentile
7.1
Low
0 — 8.8
Typical Range
8.8 — 20.1
High
20.1 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 8.8
Median 13.3
70th Percentile 20.1
Max 3 188 432.5

Progyny Inc
Glance View

In a world where the concept of family is continually evolving, Progyny Inc. emerges as a pioneer, reshaping the landscape of fertility and family-building benefits. Founded with a mission to offer comprehensive fertility solutions, the company leverages a unique combination of personalized concierge service and cutting-edge technology to meet the growing demand for reproductive health services. Progyny's role in the industry is substantial, providing a suite of tailored benefits that include fertility treatments, egg freezing, genetic testing, and support services. Through its proprietary Smart Cycle plan, Progyny stands apart by integrating these services into a single, streamlined benefits package, reducing complexities and elevating the experience for patients and employers alike. The heart of Progyny's business model lies in its collaboration with employers, offering them the opportunity to include comprehensive fertility benefits as part of their health packages. By doing so, Progyny opens the door for companies to attract and retain talent in a competitive workforce, ensuring employees have access to vital reproductive assistance. The company generates revenue by partnering with these employers, who pay for the fertility benefits as part of their employee health plans. This innovative approach not only ensures recurring income for Progyny but also aligns the company’s success with positive health outcomes for its clients. As more organizations recognize the value in supporting employees' family-building journeys, Progyny’s influence and relevance in the market continue to grow, reinforcing its standing as a leader in fertility solutions.

PGNY Intrinsic Value
37.84 USD
Undervaluation 52%
Intrinsic Value
Price $18.17
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett